Curtis Welcomes Announcement from Civica Lowering Cost of Insulin
Washington, DC, March 7, 2022
Representative John Curtis issued the following statement after the announcement from Utah founded and based Civica, Inc. (Civica, Civica Rx) to manufacture insulin at more affordable prices.
“The cost of insulin is a source of financial hardship for so many Utahns,” said Rep. Curtis. “I am heartened to hear that a Utah company is innovating to deliver this drug at an affordable out-of-pocket price. I remain committed to working on long-term solutions that support the pharmaceutical industry in reducing prescription drug prices, and I applaud Civica, Inc. for their work to transparently do so. We must harness American innovation to bring affordable medications to the marketplace.”